Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.

Blood - 2 Mar 2023

Hiwase Devendra, Hahn Christopher, Tran Elizabeth Ngoc Hoa, Chhetri Rakchha, Baranwal Anmol, Al-Kali Aref, Sharplin Kirsty, Ladon Dariusz, Hollins Rachel, Greipp Patricia, Kutyna Monika, Alkhateeb Hassan, Badar Talha, Wang Paul, Ross David M, Singhal Deepak, Shanmuganathan Naranie, Bardy Peter, Beligaswatte Ashanka, Yeung David, Litzow Mark R, Mangaonkar Abhishek, Giri Pratyush, Lee Cindy, Yong Angie, Horvath Noemi, Singhal Nimit, Gowda Raghu, Hogan William, Gangat Naseema, Patnaik Mrinal, Begna Kebede, Tiong Ing S, Wei Andrew, Kumar Sharad, Brown Anna, Scott Hamish, Thomas Daniel, Kok Chung H, Tefferi Ayalew, Shah Mithun Vinod

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Leukemia, Myeloid, Acute
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myeloproliferative Disorders

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 36574363
DOI: 10.1182/blood.2022018236

Provenance

PubMed metadata and Literature Corpus relationships.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.PMID 36574363Read ↗

TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.Semantic proximity Read ↗

Current State and Future Prospects of Diagnosis and Management of TP53-Mutated Myeloid Neoplasms.Semantic proximity Read ↗

Therapy-related myeloid neoplasm in a patient with TP53 mutation: a dilemma in allogeneic stem cell transplant.Semantic proximity Read ↗

Breaking the guardian of the genome: TP53 dysfunction in myeloid neoplasms.Semantic proximity Read ↗

Therapy-related myeloid neoplasms with single-hit TP53 mutations share the clinical, molecular, and survival characteristics of their multi-hit counterparts.Semantic proximity Read ↗

TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?Semantic proximity Read ↗

Therapy-related myeloid neoplasms.Semantic proximity Read ↗

What have we learned about TP53-mutated acute myeloid leukemia?Semantic proximity Read ↗

TP53 mutations in myeloid neoplasms: implications for accurate laboratory detection, diagnosis, and treatment.Semantic proximity Read ↗

Preexisting TP53 mutation in therapy-related acute myeloid leukemia.Semantic proximity Read ↗

TP53 -Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk-Stratification, and Management.Semantic proximity Read ↗

TP53 mutations in therapy-related acute myeloid leukemia: still the dark side of the moon?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.